Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00265-7/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-9r-mrd0yoEGnp1oEBx-S39jYPfCnPFIPIbU8VPd-YGO13je8ebAz8zb9UQYYy_Z_8_WFx9xBu8OBVy4tFsIhmU1Zasrw&utm_content=271743104&utm_source=hs_email